Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Genotype and severity of long QT syndrome.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Source:
    Drug Metabolism and Disposition; April 2001, Vol. 29 Issue: 4 p574-9, 6p
  • Additional Information
    • Publication Year:
      2001
    • Abstract:
      Sudden cardiac death occurs in the United States with an incidence greater than 300,000 persons per year. The underlying cause of death is commonly considered to be due to primary or secondary arrhythmias. In cases in which no structural heart disease can be identified, the long QT syndromes (LQTS) are now commonly considered as likely causes. Multiple genes causing LQTS have been identified thus far, all encoding cardiac ion channels. These include two potassium channel alpha-subunits (KVLQT1, HERG), two potassium channel beta-subunits (minK, MiRP1), and one sodium channel gene (SCN5A). The purpose of this review is to describe the current understanding of the molecular genetics of LQTS and the resultant phenotypes.
    • ISSN:
      00909556; 1521009X
    • Accession Number:
      ejs5545257
  • Citations
    • ABNT:
      Genotype and severity of long QT syndrome. Drug Metabolism and Disposition, [s. l.], v. 29, n. 4, p. 574–9, 2001. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edo&AN=ejs5545257. Acesso em: 22 out. 2020.
    • AMA:
      Genotype and severity of long QT syndrome. Drug Metabolism and Disposition. 2001;29(4):574-579. Accessed October 22, 2020. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edo&AN=ejs5545257
    • APA:
      Genotype and severity of long QT syndrome. (2001). Drug Metabolism and Disposition, 29(4), 574–579.
    • Chicago/Turabian: Author-Date:
      “Genotype and Severity of Long QT Syndrome.” 2001. Drug Metabolism and Disposition 29 (4): 574–79. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edo&AN=ejs5545257.
    • Harvard:
      ‘Genotype and severity of long QT syndrome’ (2001) Drug Metabolism and Disposition, 29(4), pp. 574–9. Available at: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edo&AN=ejs5545257 (Accessed: 22 October 2020).
    • Harvard: Australian:
      ‘Genotype and severity of long QT syndrome’ 2001, Drug Metabolism and Disposition, vol. 29, no. 4, pp. 574–9, viewed 22 October 2020, .
    • MLA:
      “Genotype and Severity of Long QT Syndrome.” Drug Metabolism and Disposition, vol. 29, no. 4, Apr. 2001, pp. 574–9. EBSCOhost, search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edo&AN=ejs5545257.
    • Chicago/Turabian: Humanities:
      “Genotype and Severity of Long QT Syndrome.” Drug Metabolism and Disposition 29, no. 4 (April 1, 2001): 574–79. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edo&AN=ejs5545257.
    • Vancouver/ICMJE:
      Genotype and severity of long QT syndrome. Drug Metabolism and Disposition [Internet]. 2001 Apr 1 [cited 2020 Oct 22];29(4):574–9. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edo&AN=ejs5545257